Ethics & Compliance

At Boehringer Ingelheim*, we prioritise the establishment and maintenance of public trust. Transparency is a key pillar of our corporate culture, as well as a vital principle in healthcare compliance. 

We are committed to legal and regulatory compliance and aim to comply with all legal and regulatory codes and obligations including those required by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Association of the British Pharmaceutical Industry (ABPI), the Irish Pharmaceutical Healthcare Association (IPHA), the National Office of Animal Health (NOAH), the Animal and Plant Health Agency (APHA) and those imposed under US laws such as the Sunshine Act.

As part of this, we comply with the EFPIA Pharma Transparency (Disclosure) Code which requires all pharmaceutical companies to disclose all transfers of value to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) on an annual basis in arrears, starting with 2015 data. Details of these transfers can be found on the Disclosure UK section of the ABPI website.

In our Boehringer Ingelheim Code of Conduct, we emphasise our objective and commitment that “we act with integrity, are trustworthy and set a good example”.

With Integrity and Passion

Our Global Code of Conduct

Our FOCUS articulates who we are, how we work and what we want to achieve. The Core of the Leitbild, the “who we are,” states that we aim to be driven by results, working with integrity and passion. The “how we work” helps us to achieve our Ambition 2025.

Our Code of Conduct demonstrates for each and every one that integrity is “part of our DNA”.  We act in a global environment, and are all entrusted to make decisions that impact our reputation and relationships with each other, our customers, our business partners and the public.

Our Code of Conduct is the guide for our actions and behavior both within the company and externally. We comply with the laws and are guided by our ethical principles as we conduct business at Boehringer Ingelheim.

We, the Board of Managing Directors are fully committed to compliance with the law and these ethical principles, and ask for your commitment.

Hubertus v. Baumbach, Joachim Hasenmaier, Allan Hillgrove, Andreas Neumann, Michel Pairet and Michael Schmelmer

Our ethical & compliance standards

For more information about the standards we meet through our Code of Conduct, we specifically invite you to refer to the following key policies, statements and codes:

* Boehringer Ingelheim Limited, Boehringer Ingelheim Ireland Limited and Boehringer Ingelheim Animal Health UK Limited.

NP-IE-100018 | January 2019